Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
NAC
 
Attending: ___.
 
Major Surgical or Invasive Procedure:
None

attach
 
Pertinent Results:
___ 10:00PM BLOOD WBC-7.0 RBC-4.71 Hgb-16.0 Hct-46.5 
MCV-99* MCH-34.0* MCHC-34.4 RDW-13.7 RDWSD-49.7* Plt ___
___ 04:00PM BLOOD WBC-11.1* RBC-4.55* Hgb-15.1 Hct-45.4 
MCV-100* MCH-33.2* MCHC-33.3 RDW-14.6 RDWSD-54.0* Plt ___
___ 10:00PM BLOOD Neuts-45 Bands-1 ___ Monos-22* 
Eos-0* Baso-0 Plasma-1* AbsNeut-3.22 AbsLymp-2.17 AbsMono-1.54* 
AbsEos-0.00* AbsBaso-0.00*
___ 10:00PM BLOOD ___ PTT-45.0* ___
___ 04:00PM BLOOD ___ PTT-33.8 ___
___ 10:00PM BLOOD Glucose-85 UreaN-11 Creat-0.8 Na-135 
K-4.1 Cl-106 HCO3-18* AnGap-11
___ 04:00PM BLOOD Glucose-112* UreaN-12 Creat-0.9 Na-138 
K-4.7 Cl-100 HCO3-29 AnGap-9*
___ 10:00PM BLOOD ALT-9420* AST-2507* LD(LDH)-5195* 
CK(CPK)-86 AlkPhos-160* TotBili-2.1*
___ 04:00PM BLOOD ALT-4375* AST-1779* LD(LDH)-298* 
TotBili-6.3*
___ 10:00PM BLOOD Albumin-3.0* Calcium-7.1* Phos-2.6* 
Mg-1.6
___ 04:00PM BLOOD Calcium-8.6 Phos-3.8 Mg-2.1
___ 10:00PM BLOOD HBsAg-NEG HBsAb-NEG HBcAb-NEG IgM 
HAV-POS*
___ 06:45AM BLOOD IgM HBc-NEG
___ 06:45AM BLOOD AMA-NEGATIVE Smooth-NEGATIVE
___ 06:45AM BLOOD ___
___ 06:45AM BLOOD IgG-1631*
___ 06:45AM BLOOD EBV IgG-POS* EBNA-POS* EBV IgM-NEG 
EBVI-Results in
___ 06:45AM BLOOD HIV Ab-NEG
___ 10:00PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG 
Tricycl-NEG
___ 10:00PM BLOOD HCV Ab-NEG
___ 10:00PM BLOOD HBV VL-NOT DETECT HCV VL-NOT DETECT
___ 06:45AM BLOOD CMV VL-NOT DETECT

IMAGING
___ DUPLEX DOPP ABD/PEL; ABDOMEN US (COMPLETE STUDY)
FINDINGS:  
  
LIVER: The hepatic parenchyma appears within normal limits. The 
contour of the 
liver is smooth. There is no focal liver mass.There is no 
ascites. 
BILE DUCTS: There is no intrahepatic biliary dilation. 
  CHD: Not clearly visualized.  No evidence of extrahepatic 
biliary 
dilatation. 
GALLBLADDER: A dependent mobile echogenic focus measuring up to 
1 cm likely 
represents a calculus versus tumefactive sludge.  There is no 
gallbladder wall 
thickening. 
PANCREAS: Only the pancreatic head was seen due to bowel gas 
obscuring 
visualization of the more distal pancreas.  Imaged portion of 
the pancreas 
appears within normal limits, without masses or pancreatic 
ductal dilation. 
SPLEEN: Surgically absent. 
KIDNEYS: Limited views of the kidneys show no hydronephrosis. 
  Right kidney: 13.7 cm 
  Left kidney: 13.4 cm 
  
RETROPERITONEUM: Visualized portions of aorta and IVC are within 
normal 
limits. 
  
DOPPLER EVALUATION: 
  
The main portal vein is patent, with flow in the appropriate 
direction. 
Main portal vein velocity is 13.9 cm/sec. 
Right and left portal veins are patent, with antegrade flow. 
  
The main hepatic artery is patent, with appropriate waveform. 
Right, middle and left hepatic veins are patent, with 
appropriate waveforms. 
The truncated partially visualized splenic vein, and superior 
mesenteric vein 
are patent, with antegrade flow. 
  
IMPRESSION:  
  
1.  Patent hepatic vasculature. 
2.  Cholelithiasis without evidence of acute cholecystitis. 

 
Brief Hospital Course:
___ male PMH A. flutter on apixaban, HTN who presented 
to
OSH with abdominal pain and weakness. Found to have severe
transaminitis and transferred for further work-up. Diagnosed 
with hepatitis A. LFTs and T ___. Patient was recommended to continue being monitored 
in hospital in setting of liver injury.
However, he decide to leave against medical advice.

Transitional Issues:
[] Statin held in setting of liver injury, f/u for restart when 
appropriate
[] Apixaban held in setting of liver injury, f/u for restart 
when appropriate
[] Please follow-up AST, ALT and T ___ for resolution of liver 
injury, as patient at high risk for continued liver damage. 
Please follow up within 24 hours.
[] Patient needs hepatitis B vaccine when appropriate.

ACUTE ISSUES:
=============
# Transaminitis
No reported history of liver issues. Given severity of
transaminitis (LFTs to ___, DDx includes viral
hepatitis, Budd-Chiari syndrome, ischemic hepatitis, toxic
exposure, and medications. APAP level negative. OSH RUQ U/S
showed patent portal vein, no comment on hepatic vein. Patient 
diagnosed with hepatitis A, LFTs and T ___ were downtrending. 
Apixban was held. Patient was explained the risks and benefits 
of
leaving against medical advice, including liver injury and 
death,
but decided to leave against medical advice.

# Coagulopathy: Medication v. hepatic dysfunction. Will hold
apixaban while inpatient given concurrent hepatocellular injury.

# A. flutter: Recently cardioverted at ___ on ___. 
- continued to hold apixaban at this time
- Continued Metoprolol Succinate XL 50 mg PO daily 
- Held Atorvastatin while inpatient given transaminitis 

CHRONIC ISSUES:
===============
# HLD: Held atorvastatin given transaminitis 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Metoprolol Succinate XL 50 mg PO DAILY 
2. Apixaban 5 mg PO BID 
3. Atorvastatin 40 mg PO QPM 
4. Omeprazole 20 mg PO DAILY 

 
Discharge Medications:
1.  Metoprolol Succinate XL 50 mg PO DAILY  
2.  Omeprazole 20 mg PO DAILY  
3. HELD- Apixaban 5 mg PO BID  This medication was held. Do not 
restart Apixaban until PCP ___
4. HELD- Atorvastatin 40 mg PO QPM  This medication was held. Do 
not restart Atorvastatin until hold until pcp approves and liver 
recovers
5.Outpatient Lab Work
CBC, LFTs, T ___, direct ___

 
___ Disposition:
Home
 
Discharge Diagnosis:
hepatitis A

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
======================  
DISCHARGE INSTRUCTIONS  
======================  
Dear Mr. ___,

It was a privilege caring for you at ___.  

WHY WAS I IN THE HOSPITAL?  
- You had hepatitis A

WHAT HAPPENED TO ME IN THE HOSPITAL?  
- You're liver was monitored
- You were given medications to help your symptoms

WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?  
-Please continue to take all of your medications and follow-up 
with your appointments as listed below.  

We wish you the best! 
 
Sincerely,  

Your ___ Team  

 
Followup Instructions:
___